Found: 15
Select item for more details and to access through your institution.
Intracellular and plasma pharmacokinetics of 400 mg of etravirine once daily versus 200 mg of etravirine twice daily in HIV-infected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 3, p. 681, doi. 10.1093/jac/dkr534
- By:
- Publication type:
- Article
Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 11, p. 2605
- By:
- Publication type:
- Article
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2015, v. 34, n. 9, p. 1879, doi. 10.1007/s10096-015-2426-6
- By:
- Publication type:
- Article
Liver Fibrosis, Host Genetic and Hepatitis C Virus Related Parameters as Predictive Factors of Response to Therapy against Hepatitis C Virus in HIV/HCV Coinfected Patients.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0101760
- By:
- Publication type:
- Article
HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients.
- Published in:
- PLoS ONE, 2014, v. 9, n. 6, p. 1, doi. 10.1371/journal.pone.0099468
- By:
- Publication type:
- Article
Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0048959
- By:
- Publication type:
- Article
Influence of IL28B Polymorphisms on Response to a Lower-Than-Standard Dose peg-IFN-α 2a for Genotype 3 Chronic Hepatitis C in HIV-Coinfected Patients.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0028115
- By:
- Publication type:
- Article
CD4+ T cell restoration and control of hepatitis C virus replication after childbirth.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Deep Eutectic Solvents for the Extraction of Bioactive Compounds from Natural Sources and Agricultural By-Products.
- Published in:
- Applied Sciences (2076-3417), 2021, v. 11, n. 11, p. 4897, doi. 10.3390/app11114897
- By:
- Publication type:
- Article
Role of Ritonavir in the Drug Interactions Between Telaprevir and Ritonavir-Boosted Atazanavir.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. 2, p. 268, doi. 10.1093/cid/cit693
- By:
- Publication type:
- Article
Risk of Liver Decompensation Among HIV/Hepatitis C Virus–Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. 10, p. 1401, doi. 10.1093/cid/cit537
- By:
- Publication type:
- Article
Low concordance and resistance mutation emergence in the HIV protease gene among circulating and cell-associated viruses at viral replication episodes during darunavir/ritonavir monotherapy.
- Published in:
- HIV Medicine, 2015, v. 16, n. 1, p. 57, doi. 10.1111/hiv.12170
- By:
- Publication type:
- Article
Impact of the peginterferon-α 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/ HIV-co-infected patients with the unfavourable non- CC IL28B genotypes.
- Published in:
- Journal of Viral Hepatitis, 2014, v. 21, n. 3, p. 178, doi. 10.1111/jvh.12128
- By:
- Publication type:
- Article
Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus–Coinfected Patients With Compensated Cirrhosis.
- Published in:
- Clinical Infectious Diseases, 2013, v. 56, n. 11, p. 1646
- By:
- Publication type:
- Article